Tag: thrombectomy

New data show Penumbra’s Indigo aspiration system used in a single...

During the Society of Interventional Radiology (SIR) 2024 annual meeting (23–28 March, Salt Lake City, USA), newly presented data from a subgroup analysis of...

Innova Vascular announces successful early commercial use of Laguna thrombectomy system...

Innova Vascular has announced successful early commercial use of the company's Laguna thrombectomy system. Physicians at UCLA Medical Center in Los Angeles, USA, and...
Pounce LP

Surmodics announces successful early clinical use of Pounce LP thrombectomy system

Surmodics has announced successful early clinical use of the company’s Pounce LP (low-profile) thrombectomy system. The Pounce LP system, which received US Food and Drug...
PEERLESS

Inari Medical announces first patient enrolment in PEERLESS II randomised controlled...

Inari Medical has announced the first patient enrolment in PEERLESS II. This prospective, global, multicentre randomised controlled trial (RCT) compares the outcomes of intermediate-risk...

First patient enrolled in STORM-PE RCT evaluating Penumbra’s Lightning Flash for...

Penumbra today announced that the first patient has been enrolled in STORM-PE, a prospective, multicentre, randomised controlled trial (RCT) evaluating anticoagulation alone versus anticoagulation...
Akura

Akura thrombectomy system for PE appears safe and demonstrates reduction of...

Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...

Evident Vascular exits stealth with US$35 million Series A funding to...

Evident Vascular, a medical technology startup developing an intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, recently announced...

Surmodics receives 510(k) clearance for Pounce LP thrombectomy system

Surmodics announced in a press release that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Pounce LP (low...
thrombectomy

Mechanical thrombectomy: ClotTriever offers “extended window” for DVT treatment

This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies. During a recent webinar hosted by Inari Medical, a multidisciplinary group...

First patient enrolled in PROWL registry study using Pounce thrombectomy system

Surmodics has announced enrolment of the first patient in PROWL, the Pounce thrombectomy system retrospective registry. PROWL is an open-label, retrospective, multicentre US registry...

RESCUE trial shows reduction in segmental and main pulmonary artery occlusions

Robert A Lookstein, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital (New...
top 10

Vascular News’ top 10 most popular stories of January 2023

January's top 10 highlights an individual patient data meta-analysis on the safety of carotid endarterectomy in the elderly and a new randomised trial on...

Cardiovascular Systems announces US FDA 510(k) submission of Innova Vascular’s thrombectomy...

Cardiovascular Systems (CSI) announced that Innova Vascular (Innova) has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its...

New mechanical thrombectomy systems unlock possibilities for the treatment of venous...

This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies. Mechanical thrombectomy with the ClotTriever and FlowTriever systems (Inari Medical) opens...

Penumbra and Asahi Intecc partner to introduce Indigo System to Japan

Penumbra and Asahi Intecc, a Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo Aspiration System into the Japanese market...
Auryon

AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system

AngioDynamics recently announced that it has received US Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system...
Surmodics

Pounce thrombectomy system first-in-human data show 100% technical success in early...

Surmodics has announced that its Pounce thrombectomy system achieved 100% technical success in 20 first-in-human (FIH) procedures. The FIH data were presented by Gary...

Penumbra announces the European launch of the Indigo system with Lightning...

Penumbra has announced that its Indigo aspiration system with Lightning 7 and Lightning 12 have secured CE mark and are now commercially available in...
truvic766x512

Truvic announces US FDA 510(k) clearance for Prodigy thrombectomy system

Truvic Medical, a wholly owned subsidiary of Imperative Care, announced in a press release that it has received 510(k) clearance from the US Food...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Peripheral Orbital atherectomy system

Cardiovascular Systems partners with Innova Vascular to develop full line of...

Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.  According to a...

Boston Scientific announces agreement to acquire Devoro Medical

Today, Boston Scientific announced an agreement to acquire Devoro Medical, developer of the Wolf thrombectomy platform. The non-console and lytic-free Wolf technology targets and...

Abbott expands peripheral vascular offerings with acquisition of Walk Vascular

Abbott announced today that it has acquired Walk Vascular, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to...
Surmodics

Surmodics announces successful first patient use of Pounce thrombectomy system

Surmodics has announced that J. Michael Bacharach, a vascular interventionalist/cardiologist at North Central Heart, a division of Avera Heart Hospital in Sioux Falls, USA,...

Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical

Surmodics recently announced that it has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous...
Auryon

AngioDynamics receives 510(k) clearance for AlphaVac mechanical thrombectomy system

AngioDynamics recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the AlphaVac mechanical thrombectomy system. According to...

Mermaid Medical Group reports full commercialisation of the D-Clot HD rotational...

Mermaid Medical Group recently announced US commercial availability of the D-Clot HD rotational thrombectomy system. As of 12 January, the company reports 25 successful...

Philips launches QuickClear mechanical thrombectomy system for blood clot removal in...

Royal Philips has announced the launch of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove...

Veryan Medical to support commercialisation of Jeti thrombectomy system in Germany

Walk Vascular and Veryan Medical have announced that Veryan Medical will support commercialisation of the Jeti peripheral thrombectomy system (Walk Vascular) in Germany. Walk Vascular’s...

FDA clears Aspire MAX mechanical thrombectomy system

Control Medical Technology has announced that the US Food and Drug Administration (FDA) has cleared its Aspire MAX 7 – 11F mechanical thrombectomy...
LeMaitre Vascular

LeMaitre Vascular acquires clot management business from Applied Medical

LeMaitre Vascular has acquired the vascular clot management business of Applied Medical Resources Corporation for US$14.2 million, of which US$11 million was paid at...

Philips acquires CardioProlific

  Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial...